Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001871 · ClinicalTrials.gov registry record
Study of Muscle Abnormalities in Patients With Specific Genetic Mutations
A clinical trial of Cardiomyopathy, Hypertrophic and Muscular Dystrophy, Oculopharyngeal, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT00001871: Completed study of Cardiomyopathy, Hypertrophic and Muscular Dystrophy, Oculopharyngeal, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00001871 is a study of Cardiomyopathy, Hypertrophic and Muscular Dystrophy, Oculopharyngeal that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 80 participants, below the 360-participant average among 6 other Cardiomyopathy, Hypertrophic trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001871, a study of Cardiomyopathy, Hypertrophic and Muscular Dystrophy, Oculopharyngeal, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypertrophic cardiomyopathy (HCM) is a genetically inherited disease affecting the heart. It causes thickening of heart muscle, especially the chamber responsible for pumping blood out of the heart, the left ventricle. This condition can cause patients to experience symptoms of chest pain, shortness of breath, fatigue, and heart beat palpitations. Researchers believe the disease may be caused by abnormalities in the genes responsible for producing proteins of the heart muscle. Oculopharyngeal muscular dystrophy (OPMD) is another genetically inherited disease. This condition affects the muscles of the eyes and throat causing symptoms of weak eye movements, difficulty swallowing and speaking, and weakness of the arms and legs. In previous studies researchers have found that several patients with hypertrophic cardiomyopathy (HCM) also had oculopharyngeal muscular dystrophy (OPMD). Researchers are interested in learning more about how these two diseases are associated with each other. In this study, researcher plan to collect samples of muscles (skeletal muscle biopsies) from patients belonging to families in which several members have inherited one or both of these diseases. The muscle samples will be used to link the muscle abnormalities with the specific genetic mutations. Patients participating in this study may not be directly benefited by it. However, information gathered because of this study may be used to develop better techniques for diagnosing and treating these conditions.
Conditions Studied
Study Locations (1)
Maryland
- National Heart, Lung and Blood Institute (NHLBI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 1999-01 |
| Est. Completion | 2001-03 |
What the finished NCT00001871 record still lists
NCT00001871 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 360-participant average among 6 other Cardiomyopathy, Hypertrophic trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Cardiomyopathy, Hypertrophic appearing as the primary indexed condition, and to 0 interventions.
NCT00001871 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001871 about?
NCT00001871 is a clinical study titled "Study of Muscle Abnormalities in Patients With Specific Genetic Mutations". Hypertrophic cardiomyopathy (HCM) is a genetically inherited disease affecting the heart. It causes thickening of heart muscle, especially the chamber responsible for pumping blood out of the heart, the left ventricle. This condition can cause patients to experience symptoms of chest pain, shortness...
What is the current status of trial NCT00001871?
This trial is currently completed. The enrollment target is 80 participants. The study started on 1999-01. Estimated completion is 2001-03.
What conditions does trial NCT00001871 study?
This clinical trial studies the following conditions: Cardiomyopathy, Hypertrophic, Muscular Dystrophy, Oculopharyngeal.
Who is sponsoring clinical trial NCT00001871?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001871 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiomyopathy, Hypertrophic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
RECRUITING
-
A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
ACTIVE NOT RECRUITING · Phase 4
-
Study of Exercise Training in Hypertrophic Cardiomyopathy
COMPLETED · NA
-
The Impact of Exercise-Induced Cardiac Remodeling on Myocardial Efficiency
COMPLETED
-
Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia